期刊文献+

Liver fibrosis caused by choledocholith to regress after biliary drainage

Liver fibrosis caused by choledocholith to regress after biliary drainage
下载PDF
导出
摘要 AIM: To study the correlation between liver flbrosis severity and biliary drainage in patients with choledocholith. METHODS: A follow-up study on seven patients with liver fibrosis due to choledocholith was made. The data, including biochemical tests (aspartate aminotransferase, alanine aminotransferase) and liver histological features before and after biliary drainage, were collected and studied. The fibrosis severity was scored on a scale from 0 to 3, with 0 denoting none, 1 portal and periportal fibrosis, 2 the presence of numerous fiber septa, and 3 cirrhosis. The average liver fibrosis severity scores of the first and second biopsy were compared with statistical method. RESULTS: The first, second liver fibrosis severity scores of these seven patients were 2,1; 2,1; 1,0; 1,1; 2,1; 2,1; 1,0 respectively. The results showed that the average liver fibrosis severity score of the second liver biopsy decreased significantly compared with the first liver biopsy (n=7,t=4.25,P<0.05). CONCLUSION: Liver fibrosis due to choledocholith may regress after biliary drainage. AIM: To study the correlation between liver fibrosis severity and biliary drainage in patients with choledocholith.METHODS: A follow-up study on seven patients with liver fibrosis due to choledocholith was made. The data, including biochemical tests (aspartate aminotransferase, alanine aminotransferase) and liver histological features before and after biliary drainage, were collected and studied. The fibrosis severity was scored on a scale from 0 to 3, with 0 denoting none, 1 portal and periportal fibrosis, 2 the presence of numerous fiber septa, and 3 cirrhosis. The average liver fibrosis severity scores of the first and second biopsy were compared with statistical method.RESULTS: The first, second liver fibrosis severity scores of these seven patients were 2,1; 2,1; 1,0; 1,1; 2,1; 2,1;1,0 respectively. The results showed that the average liver fibrosis severity score of the second liver biopsy decreased significantly compared with the first liver biopsy (n = 7, t = 4.25, P<0.05).CONCLUSION: Liver fibrosis due to choledocholith may regress after biliary drainage.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第13期2013-2015,共3页 世界胃肠病学杂志(英文版)
关键词 Liver fibrosis REGRESS Biliary drainage 肝纤维化 胆总管结石 胆汁排泄 病理机制
  • 相关文献

参考文献12

  • 1Donato MF, Arosio E, Del Ninno E, Ronchi G, Lampertico P,Morabito A, Balestri MR, Colombo M. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology 2001; 34:523-528.
  • 2Jiang Y, Liu J, Waalkes M, Kang YJ. Changes in the gene expression associated with carbon tetrachloride-induced liver fibrosis persist after cessation of dosing in mice. Toxicol Sci2004; 5:31.
  • 3Heistermann HP, Palmes D, Hierlemann H, Ebsen M,Horstmann R, Hohlbach G, Spiegel HU. Reconstruction of bil duct lesions by an autologous vein graft and a bio-degradable endoluminal stent in an animal model: technique and clinical impact. Zentralbl Chfr 2003; 128:952-957.
  • 4Dahab GIrl, Kheriza MM, E1-Beltagi HM, Fouda AM, El-DinOA. Digital quantification of fibrosis in liver biopsr sections:description of a new method by Photoshop software. J Gastroenterol Hepatol 2004; 19:78-85.
  • 5Muriel P, Moreno MG. Effects of silymarin and vitamins Eand C on liver damage induced by prolonged biliary obstruction in the rat. Basic Clin Pharmacol Toxicol 2004; 94:99-104.
  • 6Ainsworth AP, Rafaelsen SR, Wamberg PA, Durup J, PlessTK, Mortensen MB. Is there a difference in diagnostic accuracy and clinical impact between endoscopic ultrasonography and magnetic resonance cholangiopancreatography?Endoscopy 2003; 35:1029-1032.
  • 7Lorena D, Darby IA, Reinhardt DP, Sapin V, Rosenbaum J,Desmouliere A. Fibrillin-1 expression in normal and fibrotic rat liver and in cultured hepatic fibroblastic cells: modulation by mechanical stress and role in cell adhesion. Lab Invest 2004;84:203-212.
  • 8Refik Mas M, Comert B, Oncu K, Vural SA, Akay C, Tasci I,Ozkomur E, Serdar M, Mas N, Alcigir G, Yener N. The effect of taurine treatment on oxidative stress in experimental liver fibrosis. Hepatol Res 2004; 28:207-215.
  • 9Serviddio G, Pereda J, Pallardo FV, Carretero J, Borras C,Cutrin J, Vendemiale G, Poli G, Vina J, Sastre J. Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress. Hepatology 2004;39:711-720.
  • 10Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal.Hepatology 2003; 37:493-503.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部